Work

Combined Treatment for Patients with Brain Metastases from Non-small Cell Lung Cancer with Whole Brain Radiotherapy (WBRT) and Gefitinib (GFT) or Temozolomide (TMZ). A Randomized Multicenter Phase II Trial of the Swiss Group of Clinical Cancer Research (SAKK #70/03)

Year: 2010

Type: article

Study design: Clinical Trial

Source: International Journal of Radiation Oncology*Biology*Physics

DOI: 10.1016/j.ijrobp.2010.07.615

Authors: G.A. Pesce, R. Von Moos, G. D'Addario, N. Fischer, C.B. Caspar, S. Anchisi, N. Kotrubczik, A. Zouhair, M. Mayer, R. Stupp

Institutions: Istituto Oncologico della Svizzera Italiana, Kantonsspital Graubünden, Kantonsspital St. Gallen, University Hospital of Basel, Kantonsspital Baden, Kantonsspital Aarau, Centre Hospitalier Universitaire Vaudois, Swiss Group For Clinical Cancer Research

Language: English

Topic: Brain Metastases and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1967041788

FWCI:

Cites:

Cited by:

Related to: 10